30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Acucela Inc (4589)

Track

Stock chart
Ticker: 4589 Exchange: TYO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SCHEIBLER LUKAS
EVP of Research & Development
1 sale — total 8,125 USD
Sale 17 Jul 2017
Value US$4,967,705.18 | Price 283.59 | Shares 69,470
Sale 5 Jul 2017
Value US$3,733,191.45 | Price 30.47 | Shares 78,806
Sale 5 Jul 2017
Value US$7,931.25 | Price 6.75 | Shares 1,175
Sale 20 Jun 2017
Value US$9,035.00 | Price 6.95 | Shares 1,300
Sale 1 Jun 2017
Value US$24,944.40 | Price 7.38 | Shares 3,380
Sale 1 Jun 2017
Value US$7,970.40 | Price 7.38 | Shares 1,080
Sale 17 May 2017
Value US$7,841.25 | Price 6.15 | Shares 1,275
Sale 1 May 2017
Value US$22,232.25 | Price 6.15 | Shares 3,615
Sale 1 May 2017
Value US$6,765.00 | Price 6.15 | Shares 1,100
Sale 17 Apr 2017
Value US$8,553.60 | Price 6.48 | Shares 1,320
Sale 4 Apr 2017
Value US$22,950.00 | Price 6.75 | Shares 3,400
Sale 4 Apr 2017
Value US$7,425.00 | Price 6.75 | Shares 1,100
Sale 20 Mar 2017
Value US$8,875.00 | Price 7.10 | Shares 1,250
Sale 2 Mar 2017
Value US$27,335.00 | Price 7.70 | Shares 3,550
Sale 2 Mar 2017
Value US$9,650.00 | Price 7.72 | Shares 1,250
Sale 17 Feb 2017
Value US$11,745.00 | Price 8.10 | Shares 1,450
Sale 2 Feb 2017
Value US$33,325.00 | Price 8.60 | Shares 3,875
Sale 2 Feb 2017
Value US$10,625.00 | Price 8.50 | Shares 1,250
Buy 23 Jan 2017
Value US$2,591,063,212.00 | Price 150,643.21 | Shares 17,200
Buy 20 Jan 2017
Value US$1,443,307,857.00 | Price 111,884.33 | Shares 12,900
Buy 19 Jan 2017
Value US$86,960.00 | Price 869.60 | Shares 100
Sale 18 Jan 2017
Value US$12,832.50 | Price 8.70 | Shares 1,475
Buy 12 Jan 2017
Value US$450,475,972.00 | Price 63,447.32 | Shares 7,100
Sale 4 Jan 2017
Value US$32,518.20 | Price 8.58 | Shares 3,790
Sale 4 Jan 2017
Value US$10,896.60 | Price 8.58 | Shares 1,270
Buy 30 Dec 2016
Value US$62,019,135.00 | Price 22,970.05 | Shares 2,700
Buy 29 Dec 2016
Value US$2,425,270,497.00 | Price 143,507.13 | Shares 16,900
Buy 28 Dec 2016
Value US$355,376,994,304.00 | Price 1,735,239.23 | Shares 204,800
Sale 22 Dec 2016
Value US$7,198.40 | Price 8.18 | Shares 880
Sale 22 Dec 2016
Value US$26,257.80 | Price 8.18 | Shares 3,210
Sale 15 Dec 2016
Value US$9,537.50 | Price 8.75 | Shares 1,090
Sale 21 Nov 2016
Value US$24,890.53 | Price 9.35 | Shares 2,663
Sale 14 Nov 2016
Value US$16,745.50 | Price 9.44 | Shares 1,774
Sale 29 Sep 2016
Value US$117,829.80 | Price 13.09 | Shares 9,000
Sale 20 Sep 2016
Value US$25,381.59 | Price 9.53 | Shares 2,663
Sale 12 Sep 2016
Value US$591,420.00 | Price 9.86 | Shares 60,000
Sale 31 Aug 2016
Value US$251,130.52 | Price 10.04 | Shares 25,013
Sale 18 Aug 2016
Value US$345,509.22 | Price 10.81 | Shares 31,962
Sale 18 Aug 2016
Value US$811,841.81 | Price 10.81 | Shares 75,101
Buy 27 Jun 2016
Value US$13,684,270.00 | Price 22.15 | Shares 617,800
Buy 24 Jun 2016
Value US$8,456,862.00 | Price 17.67 | Shares 478,600
Buy 23 Jun 2016
Value US$18,878,550.00 | Price 19.05 | Shares 991,000
Buy 22 Jun 2016
Value US$7,398,244.00 | Price 16.21 | Shares 456,400
Buy 21 Jun 2016
Value US$8,952,150.00 | Price 16.13 | Shares 555,000
Buy 20 Jun 2016
Value US$11,592,896.00 | Price 16.03 | Shares 723,200
Buy 17 Jun 2016
Value US$9,727,039.00 | Price 12.53 | Shares 776,300
Buy 16 Jun 2016
Value US$2,860,410.00 | Price 11.13 | Shares 257,000
Buy 15 Jun 2016
Value US$9,471,120.00 | Price 9.30 | Shares 1,018,400
Buy 3 Jun 2016
Value US$2,468,169.00 | Price 9.63 | Shares 256,300
Buy 2 Jun 2016
Value US$3,452,400.00 | Price 10.08 | Shares 342,500
Sale 26 Aug 2014
Value US$448,152.00 | Price 7.89 | Shares 56,800
Sale 18 Aug 2014
Value US$285,525.00 | Price 7.05 | Shares 40,500
Sale 13 Mar 2014
Value US$22,107,600.00 | Price 16.02 | Shares 1,380,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-07-18 2017-07-17 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
69,470 -49.6%
283.59
US$4,967,705 		69,470 -49.6% 283.59 US$4,967,705
2017-07-05 2017-07-05 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
78,806 -34.2%
30.47
US$3,733,191 		78,806 -34.2% 30.47 US$3,733,191
2017-07-05 2017-07-05 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
97,564 -28.0%
75.61
US$2,556,502 		97,564 -28.0% 75.61 US$2,556,502
2017-06-20 2017-06-20 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,300 -11.8%
6.95
US$9,035 		1,300 -11.8% 6.95 US$9,035
2017-06-02 2017-06-01 S Sale GEBHART JOHN E

Chief Financial Officer
3,380 -7.7%
7.38
US$24,944 		3,380 -7.7% 7.38 US$24,944
2017-06-02 2017-06-01 S Sale
DANSE EDWARD H

Chief Business Officer
1,080 -1.5%
7.38
US$7,970 		1,080 -1.5% 7.38 US$7,970
2017-05-18 2017-05-17 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
1,275 -13.3%
6.15
US$7,841 		1,275 -13.3% 6.15 US$7,841
2017-05-02 2017-05-01 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
3,615 -9.1%
6.15
US$22,232 		3,615 -9.1% 6.15 US$22,232
2017-05-02 2017-05-01 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
1,100 -1.5%
6.15
US$6,765 		1,100 -1.5% 6.15 US$6,765
2017-04-17 2017-04-17 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,320 -16.0%
6.48
US$8,554 		1,320 -16.0% 6.48 US$8,554
2017-04-04 2017-04-04 S Sale GEBHART JOHN E

Chief Financial Officer
3,400 -9.5%
6.75
US$22,950 		3,400 -9.5% 6.75 US$22,950
2017-04-04 2017-04-04 S Sale DANSE EDWARD H

Chief Business Officer
1,100 -1.5%
6.75
US$7,425 		1,100 -1.5% 6.75 US$7,425
2017-03-20 2017-03-20 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,250 -18.3%
7.10
US$8,875 		1,250 -18.3% 7.10 US$8,875
2017-03-02 2017-03-02 S Sale GEBHART JOHN E

Chief Financial Officer
3,550 -11.1%
7.70
US$27,335 		3,550 -11.1% 7.70 US$27,335
2017-03-02 2017-03-02 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
1,250 -1.7%
7.72
US$9,650 		1,250 -1.7% 7.72 US$9,650
2017-02-21 2017-02-17 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,450 -25.7%
8.10
US$11,745 		1,450 -25.7% 8.10 US$11,745
2017-02-03 2017-02-02 S Sale GEBHART JOHN E

Chief Financial Officer
3,875 -13.7%
8.60
US$33,325 		3,875 -13.7% 8.60 US$33,325
2017-02-03 2017-02-02 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
1,250 -1.6%
8.50
US$10,625 		1,250 -1.6% 8.50 US$10,625
2017-02-08 2017-01-23 B Purchase SBI Holdings, Inc. Large shareholder
17,200 +0.2%
150,643.21
US$2,591,063,212 		17,200 +0.2% 150,643.21 US$2,591,063,212
2017-02-08 2017-01-20 B Purchase SBI Holdings, Inc. Large shareholder
12,900 +0.2%
111,884.33
US$1,443,307,857 		12,900 +0.2% 111,884.33 US$1,443,307,857
2017-02-08 2017-01-19 B Purchase SBI Holdings, Inc. Large shareholder
100 +0.0%
869.60
US$86,960 		100 +0.0% 869.60 US$86,960
2017-01-20 2017-01-18 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,475 -33.2%
8.70
US$12,832 		1,475 -33.2% 8.70 US$12,832
2017-02-08 2017-01-12 B Purchase SBI Holdings, Inc. Large shareholder
7,100 +0.1%
63,447.32
US$450,475,972 		7,100 +0.1% 63,447.32 US$450,475,972
2017-01-06 2017-01-04 S Sale GEBHART JOHN E

Chief Financial Officer
3,790 -15.4%
8.58
US$32,518 		3,790 -15.4% 8.58 US$32,518
2017-01-06 2017-01-04 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
1,270 -1.6%
8.58
US$10,897 		1,270 -1.6% 8.58 US$10,897
2017-01-10 2016-12-30 B Purchase SBI Holdings, Inc. Large shareholder
2,700 +0.0%
22,970.05
US$62,019,135 		2,700 +0.0% 22,970.05 US$62,019,135
2017-01-10 2016-12-29 B Purchase SBI Holdings, Inc. Large shareholder
16,900 +0.2%
143,507.13
US$2,425,270,497 		16,900 +0.2% 143,507.13 US$2,425,270,497
2017-01-10 2016-12-28 B Purchase SBI Holdings, Inc. Large shareholder
204,800 +2.6%
1,735,239.23
US$355,376,994,304 		204,800 +2.6% 1,735,239.23 US$355,376,994,304
2016-12-27 2016-12-22 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
880 -33.0%
8.18
US$7,198 		880 -33.0% 8.18 US$7,198
2016-12-27 2016-12-22 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
3,210 -15.8%
8.18
US$26,258 		3,210 -15.8% 8.18 US$26,258
2016-12-19 2016-12-15 S Sale DANSE EDWARD H

Chief Business Officer

Officer
1,090 -1.4%
8.75
US$9,538 		1,090 -1.4% 8.75 US$9,538
2016-11-21 2016-11-21 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
2,663 -100.0%
9.35
US$24,891 		2,663 -100.0% 9.35 US$24,891
2016-11-15 2016-11-14 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
1,774 -100.0%
9.44
US$16,745 		1,774 -100.0% 9.44 US$16,745
2016-09-30 2016-09-29 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
9,000 -68.2%
13.09
US$117,830 		9,000 -68.2% 13.09 US$117,830
2016-09-20 2016-09-20 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
2,663 -100.0%
9.53
US$25,382 		2,663 -100.0% 9.53 US$25,382
2016-09-12 2016-09-12 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
60,000 -82.0%
9.86
US$591,420 		60,000 -82.0% 9.86 US$591,420
2016-09-02 2016-08-31 S Sale DANSE EDWARD H

Chief Business Officer

Officer
25,013 -23.5%
10.04
US$251,131 		25,013 -23.5% 10.04 US$251,131
2016-08-18 2016-08-18 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
31,962 -100.0%
10.81
US$345,509 		31,962 -100.0% 10.81 US$345,509
2016-08-18 2016-08-18 S Sale DANSE EDWARD H

Chief Business Officer

Officer
75,101 -41.4%
10.81
US$811,842 		75,101 -41.4% 10.81 US$811,842
2016-07-21 2016-06-27 B Purchase SBI Holdings, Inc. Large shareholder
617,800 +8.3%
22.15
US$13,684,270 		617,800 +8.3% 22.15 US$13,684,270
2016-07-21 2016-06-24 B Purchase SBI Holdings, Inc. Large shareholder
478,600 +6.9%
17.67
US$8,456,862 		478,600 +6.9% 17.67 US$8,456,862
2016-07-21 2016-06-23 B Purchase SBI Holdings, Inc. Large shareholder
991,000 +16.7%
19.05
US$18,878,550 		991,000 +16.7% 19.05 US$18,878,550
2016-07-21 2016-06-22 B Purchase SBI Holdings, Inc. Large shareholder
456,400 +8.3%
16.21
US$7,398,244 		456,400 +8.3% 16.21 US$7,398,244
2016-07-21 2016-06-21 B Purchase SBI Holdings, Inc. Large shareholder
555,000 +11.3%
16.13
US$8,952,150 		555,000 +11.3% 16.13 US$8,952,150
2016-07-21 2016-06-20 B Purchase SBI Holdings, Inc. Large shareholder
723,200 +17.2%
16.03
US$11,592,896 		723,200 +17.2% 16.03 US$11,592,896
2016-07-21 2016-06-17 B Purchase SBI Holdings, Inc. Large shareholder
776,300 +22.6%
12.53
US$9,727,039 		776,300 +22.6% 12.53 US$9,727,039
2016-07-21 2016-06-16 B Purchase SBI Holdings, Inc. Large shareholder
257,000 +8.1%
11.13
US$2,860,410 		257,000 +8.1% 11.13 US$2,860,410
2016-07-21 2016-06-15 B Purchase SBI Holdings, Inc. Large shareholder
1,018,400 +47.3%
9.30
US$9,471,120 		1,018,400 +47.3% 9.30 US$9,471,120
2016-07-21 2016-06-03 B Purchase SBI Holdings, Inc. Large shareholder
256,300 +13.5%
9.63
US$2,468,169 		256,300 +13.5% 9.63 US$2,468,169
2016-07-21 2016-06-02 B Purchase SBI Holdings, Inc. Large shareholder
342,500 +22.0%
10.08
US$3,452,400 		342,500 +22.0% 10.08 US$3,452,400
2014-08-27 2014-08-26 S Sale DEYOUNG HIEN

VP Human Resources

Officer
56,800 -100.0%
7.89
US$448,152 		56,800 -100.0% 7.89 US$448,152
2014-08-19 2014-08-18 S Sale Lowrance David L

CFO, Secretary, Treasurer

Officer
40,500 -100.0%
7.05
US$285,525 		40,500 -100.0% 7.05 US$285,525
2014-03-17 2014-03-13 S Sale KUBOTA RYO

CEO, President and COB

Executive Director Large shareholder
1,380,000 -11.9%
16.02
US$22,107,600 		1,380,000 -11.9% 16.02 US$22,107,600
Explore more

More insider trading research around Acucela Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America